The patient, aged 65, presented with prostatic hypertrophy causing acute bladder neck obstruction. The surgeon elected to perform a suprapubic prostatectomy, and ordered usual pre-operative investigations, including two bottles of blood to be cross-matched. The patient, known to be hypertensive, was on long-term digoxin and alpha methyldopa 500 mg three times daily.
He had a past history of myocardial infarctions with residual, occasional, mild angina. He had also had a recent episode of left sided numbness attributed to vertebro-basilar artery insufficiency.
On examination, he was a fit looking man, with moderate hypertension and slight cardiomegaly. Among the results of investigations was a report from the pathology laboratory that it was impossible to cross-match blood for this man in the usual manner, his own cells giving a positive d.irect Coombs reaction, presumably due to " Aldomet "therapy. Alpha methyldopa was ceased after receiving this report and surgery was planned to take place three days later.
After consultation with the Red Cross Blood Bank, it was recommended that donor blood could be used, if necessary, provided that usual cross-matching procedures were performed, and compared with those using the patient's own cells and his serum, i.e. an auto-control. Donor blood should then be selected., the cells of which exhibited less, or certainly no greater, agglutination than the patient's own cells. It was also recommended that if transfusion became necessary this be avoided until the patient was awake, so that symptoms and more signs would be available should intravascular haemolysis take place.
The anaesthesia and surgery proceeded without any problems. The patient was given a relaxant anaesthetic, and 400 ml Hartmann's solution were followed by 500 ml of stable plasma protein solution (S.P.P.S.) during the prostatectomy. His systolic blood pressure remained between 140 and 160 mm Hg and his pulse rate 80 and 100 per minute. The blood loss in the theatre was estimated as 600 ml, with some continuing loss apparent in the urine bag. A second bottle of stable plasma protein solution was administered slowly in the ward, but no blood transfusion was considered necessary.
His post-operative course was uneventful, although his haemoglobin had dropped to 11·9 gm per cent from the preoperative value of 14·7 gm per cent.
DISCUSSION
The incidence of a positive direct Coombs test after alpha methyldopa therapy has been studied by many haematologists, and their figures vary only slightly.
Several factors have become apparent.
(1) The incidence is related to the duration of therapy. It rarely occurs before treatment has been continuing for six months, and mostly occurs after one year of treatment.
(2) The incidence is dose-dependent, and is seen to increase with increasing dosage. 1 rm/day-ll per cent incidence. 1-2 gm/day-19 per cent incidence. 2 gm/day-36 per cent inddence. (3) The incidence of frank haemolytic anaemia is less than 1 per cent in those patients who develop a positive direct Coombs test. This haemolytic anaemia is serologically similar to auto-immune haemolyti<.: anaemia and patients may have exacerbations of haemolysis precipitated by factors such as infection.
If haemolysis does occur, treatment consists of stopping the drug, blood transfusion as necessary, 'lnd occasionally steroids.
(4) The direct Coombs test takes between six months and two years to become negative after stopping therapy.
THE NATURE OF THE ANTIBODY
The nature of the antibody involved has been studied and found to be sImilar to the warm antibody of auto-immune haemolytic anaemia, that is, a 7 S, IgG antlLody with maxlmal activity at 37° C.
Other haemolytic anaemias have been observed following penicillin therapy, and also 3econdary to stibophen, quinidine, quinine, para-amino salicylic acid, some sulpha compoupds, phenacetin and other drugs. The antibody which may develop after penicillin therapy is directed against the penicillin molecule acting as haptene when attached to the red cell. Thus the direct Coombs test is positive, but the indirect Coombs test is positive only in the presence of penicillin. (Cross reactions with cephalothin sodium have been observed in in-vitro tests using blood from these patients.)
The antibody causing haemolytic anaemia secondary to therapy with the other drugs mentioned is directed solely against the drug, which is passively and loosely attached to the red cell membrane. The direct Coombs test is invariably positive, but the indirect Coombs test is likely to be negative because the drug is easily washed off.
The action of the antibody developed after alpha methyldopa therapy is not inhibited by the presence of the drug and, unlike the situation in other drug induced haemolytic anaemias, the presence of the drug is not necessary for a positive indirect Coombs test, i.e. the antibody will react with normal red cells. A similar antibody has been noted to occur secondary to L-dopa (" Larodopa ") and to mefenamic acid (" Ponstan ").
The alpha methyldopa induced antibody appears to have specificity for the Rh system, in that it does not react with Rh-null cells (i.e. those containing none of the Rh antigens).
Thus the alpha methyldopa reaction is like that of a cross-reaction whereby an exogenous agent may induce a host to produce an antibody that is accidentally reactive, to some extent, with one or more of the host's own antigens (Rh loci on the red cell membrane). It is possible that the drug, or a metabolite, becomes incorporated slowly in the red cell membrane at one ot more of the Rh loci, and possibly only during red cell maturation.
Another theory is that the Rh antigens may share a metabolic configuration with alpha methyldopa so that the antibody which is produced against alpha methyldopa has a crossreaction with the l{h antigens.
The production of the antibody in significant quantity appears to require as a stimulus a large dose of alpha methyldopa over a long period of time. Once produced it is slow to disappear. It is not known why this is so.
Three problems arise from the development of this alpha methyldopa induced antibody:
(1) The risk of haemolytic anaemia. As mentioned earlier, the incidence of this is low. It is thought to be attributable to a weak affinity of the antibody for the red cell membrane, plus the fact that haemolysis is generally related to the amount of antibody present on the cell surfaces.
(2) The difficulty performing and assessing cross-matching procedures may be cunsiderable. Panels of blood may need to be tested and compared with the patient's own cells when treated with his serum, in saline, albumin and papain, as well as indirect Coombs testing. Agglutination is likely with all these tests (except saline) and assessment must be made to select the donor blood, the cells of which agglutinated least of the units tested and certainly no more than the patlent's own cells.
(3) Since the cross-matching tests show incompatibility reactions, there is some risk of intravascular haemolysis occurring if blood transfusion becomes essential. Methods of overcoming these problems include prevention of the presence of antibody, avoiding blood transfusion and certain measures taken when blood transfusion becomes essential.
The presence of antibody might be avoided if all long-term thcrapy was of a low dosage. Regular Coombs tcsting of patients on alpha methyldopa for more than six months would enable immediate cessation of the drug should Anaesthesia and Intensive Care, Vol. II , No. 2, lWay, 1974 a positive reaction occur. Others would disagree with the necessity to do this, because of the low incidence of haemolytic anaemia and the low incidence of these patients requiring transfusion.
Since it may take up to two years for the Coombs test to revert to negative, it is apparent that withdrawal of the drug any number of weeks before surgery will be of no assistance.
Blood transfusion may be avoided during many surgical procedures provided that the patient arriving in the theatre is well hydrated and not anaemic. During anaesthesia there must be good oxygenation of the patient, and an adequate circulating volume must be maintained by replacing blood loss with crystalloid and S.P.P.S. Tissue hypoxia is >'aid not to occur until the haemoglobin level falls below 7 gm per cent, so that it is safe to allow haemoglobin to fall to 9 gm per cent. However, one would endeavour to ensure higher levels in any patient with suspected coronary or cerebrovascular artery insufficiency.
There are specific measures to be taken when, due to gross operative blood loss, blood transfusion is essential;
(1) Meticulous attention must be paid to the cross-matching procedures, so that the most compatible units of donor blood available are selected for use. (2) Whenever possible, transfusion should be performed while the patient is awake, so that the symptoms of back pain, abdominal pain, general malaise and paraesthesia may be elicited should intravascular haemolysis occur. This allows the administration of blood to be stopped before the later signs of fever, falling blood pressure, increasing pulse rate and cyanosis appear. (3) The anaesthetized patient recelvmg a transfusion should be carefully monitored. A continual assessment of blood loss is mandatory. Any rapid fall of blood pressure and increase in pulse rate, with or without cyanosis, is suggestive of a transfusion reaction, particularly if there is no sudden increase in blood loss. If any sign of intravascular haemolysis occurs, the unit of blood being administered must be stopped. Intravenous fluids must be given and blood and urine collected for testing. Should blood loss continue, further units of , , compatible" blood must be given when available.
Mannitol (20-25 gm) may be given to start an osmotic diuresis. Sodium bicarbonate (50 mEq) will help because the blood pigments are more soluble in an alkaline medium.
In the event of anuria, an appropriate anuric regime should be followed, but it should be possible to avoid this complication by early institution of the above measures. CONCLUSION Although alpha methyldopa is a widely used and effective drug in the treatment of moderate to severe hypertension its administration may result in many side-effects, most of which are not sufficiently troublesome to cause cessation of therapy. One of these side-effects is the development of an antibody resulting in a positive Coombs test in a relatively large proportion of patients. The development of this reaction may be sufficient reason for immediately withdrawing the drug because of the long period for return to normal and because of the hazards of urgent major surgery requiring blood transfusion. A similar situation exists with patients receiving L-dopa or mefenamic acid who develop this reaction.
